CMC Biologics supports the global biopharmaceutical market with manufacturing sites located in Copenhagen (Denmark) and Seattle, Washington (USA). In addition to meeting the needs of our existing customers, both sites have expansion plans in place that will ensure we are prepared for the growing demand for cGMP manufacture of biopharmaceuticals.
Our Copenhagen facility offers both mammalian and microbial manufacturing and development services, and our Seattle facility offers mammalian manufacturing and development services, including formulation development, as well as an extensive array of state-of-the-art analytical capabilities. Both facilities are capable of supporting fed-batch and perfusion processes. Both facilities offer quality services and are cGMP compliant, meeting the stringent regulations of the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA).
We welcome visitors to tour our facilities. If you’re interested in touring one of our sites, please contact us today.